|
| 36174942 | High-Dimensional Clustering of 4000 Irritable Bowel Syndrome Patients Reveals Seven Distinct Disease Subsets. | Clin Gastroenterol Hepatol | 2024 |
| 36040183 | Association of raloxifene and tamoxifen therapy with cognitive performance, odds of mild cognitive impairment, and brain MRI markers of neurodegeneration. | Cancer Med | 2023 |
| 37561108 | Changes in amount and intensity of physical activity over time in breast cancer survivors. | JNCI Cancer Spectr | 2023 |
| 37451831 | Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel. | J Med Genet | 2023 |
| 37147423 | Relationship among three common hematological premalignant conditions. | Leukemia | 2023 |
| 36623243 | Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in <i>ATM</i>, <i>BRCA1</i>, <i>BRCA2</i>, <i>CHEK2</i>, and <i>PALB2</i>. | J Clin Oncol | 2023 |
| 36617249 | Predictors of Metformin Failure: Repurposing Electronic Health Record Data to Identify High-Risk Patients. | J Clin Endocrinol Metab | 2023 |
| 36870945 | Variability in Lipid Levels and Risk for Cardiovascular Disease: An Electronic Health Record-Based Population Cohort Study. | J Am Heart Assoc | 2023 |
| 34285341 | Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans. | Leukemia | 2022 |
| 35796512 | Inflammatory biomarkers, multi-morbidity, and biologic aging. | J Int Med Res | 2022 |
| 35853817 | Surveillance mammography in older breast cancer survivors: Current practice patterns and patient perceptions. | J Geriatr Oncol | 2022 |
| 35418701 | Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women. | Sci Rep | 2022 |
| 36534173 | Financial hardship in breast cancer survivors: a prospective analysis of change in financial concerns over time. | Support Care Cancer | 2022 |
| 36418344 | The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosis. | Blood Cancer J | 2022 |
| 35969843 | Progression and survival of MBL: a screening study of 10â¿¿139 individuals. | Blood | 2022 |
| 36299252 | Employment Characteristics and Risk of Hospitalization Among Older Adults Participating in the Mayo Clinic Biobank. | Mayo Clin Proc Innov Qual Outcomes | 2022 |
| 35946834 | Factors Associated With Physical Activity Levels in Patients With Breast Cancer. | Oncologist | 2022 |
| 36375388 | Reproductive risk factors associated with breast cancer in young women by molecular subtype. | Breast | 2022 |
| 35316697 | A hybrid model to identify fall occurrence from electronic health records. | Int J Med Inform | 2022 |
| 35042965 | Rare germline copy number variants (CNVs) and breast cancer risk. | Commun Biol | 2022 |
| 35331649 | Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study. | Genet Med | 2022 |
| 35169244 | Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosis. | Leukemia | 2022 |
| 34775068 | QT prolongation in patients with index evaluation for seizure or epilepsy is predictive of all-cause mortality. | Heart Rhythm | 2022 |
| 32203143 | Risk of serious infection among individuals with and without low count monoclonal B-cell lymphocytosis (MBL). | Leukemia | 2021 |
| 33718782 | Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events. | Mayo Clin Proc Innov Qual Outcomes | 2021 |
| 33802509 | Genetic Predictors of Chemotherapy-Induced Peripheral Neuropathy from Paclitaxel, Carboplatin and Oxaliplatin: NCCTG/Alliance N08C1, N08CA and N08CB Study. | Cancers (Basel) | 2021 |
| 33578652 | Genetic Variations and Health-Related Quality of Life (HRQOL): A Genome-Wide Study Approach. | Cancers (Basel) | 2021 |
| 33603442 | No Association Between Pharmacogenomics Variants and Hospital and Emergency Department Utilization: A Mayo Clinic Biobank Retrospective Study. | Pharmgenomics Pers Med | 2021 |
| 34672684 | Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast. | J Clin Oncol | 2021 |
| 34103314 | Longitudinal cohorts for harnessing the electronic health record for disease prediction in a US population. | BMJ Open | 2021 |
| 33990587 | Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. | Nat Commun | 2021 |
| 34101481 | Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score. | J Clin Oncol | 2021 |
| 34069208 | Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies? | Cancers (Basel) | 2021 |
| 33986611 | Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter]. | Pharmgenomics Pers Med | 2021 |
| 34292776 | Risk of Late-Onset Breast Cancer in Genetically Predisposed Women. | J Clin Oncol | 2021 |
| 34146516 | Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element. | Am J Hum Genet | 2021 |
| 34362097 | N-Terminal Pro Brain Natriuretic Peptide, sST2, and Galectin-3 Levels in Breast Cancer Survivors. | J Clin Med | 2021 |
| 33471974 | A Population-Based Study of Genes Previously Implicated in Breast Cancer. | N Engl J Med | 2021 |
| 32359158 | Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk. | J Natl Cancer Inst | 2021 |
| 31378813 | Cohort Profile: The Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment Protocol (RIGHT Protocol). | Int J Epidemiol | 2020 |
| 31949161 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis. | Nat Commun | 2020 |
| 33022221 | Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk. | Am J Hum Genet | 2020 |
| 32582289 | Impact of Diverse Data Sources on Computational Phenotyping. | Front Genet | 2020 |
| 32117849 | Characteristics Associated With Recruitment and Re-contact in Mayo Clinic Biobank. | Front Public Health | 2020 |
| 32439869 | Inferring multimodal latent topics from electronic health records. | Nat Commun | 2020 |
| 32327712 | Assessing the stability of biobank donor preferences regarding sample use: evidence supporting the value of dynamic consent. | Eur J Hum Genet | 2020 |
| 32292118 | An assessment of patient perspectives on pharmacogenomics educational materials. | Pharmacogenomics | 2020 |
| 32128228 | Colorectal cancer outcomes after screening with the multi-target stool DNA assay: protocol for a large-scale, prospective cohort study (the Voyage study). | BMJ Open Gastroenterol | 2020 |
| 32253604 | Real-world experiences with acupuncture among breast cancer survivors: a cross-sectional survey study. | Support Care Cancer | 2020 |
| 32125938 | Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer. | J Clin Oncol | 2020 |